On October 18th 2018, the Hunter Medical Research Institute and the Mark Hughes Foundation welcomed international brain cancer expert Dr. Susan Chang and Research Fellow Dr. Mike Fay to speak on their current research at the Brain Cancer Public Seminar. The two world leading researchers, Dr Mike Fay and Dr Susan Chang talked about their current and future brain cancer treatments and exciting research being undertaken in the Hunter and treatments from across the globe.
To view specialist talks, and video's from the forum, please click on the video below:
Dr Mike Fay is a nationally renowned radiation oncologist who was the inaugural recipient of the HMRI Mid-Career research Fellowship in Brain Cancer supported by the Mark Hughes Foundation. Mike’s research focusses on specially targeted therapies based on targeted diagnostic tests.
Dr Susan Chang is the Director of the UCSF Division of Neuro-Oncology and is an internationally recognized leader in the field of neurological malignancies. Her research expertise is in clinical trial design and the development of novel therapies and imaging biomarkers for brain tumors. Dr. Chang is the principal investigator and co-investigator on more than 20 active clinical trials that evaluate the wide spectrum of therapeutic interventions, spanning chemotherapy, targeted agents, immunotherapy, and convection-enhanced delivery of novel agents. Dr. Chang also has a strong interest in quality-of-life issues faced by patients with brain tumors and their families.